Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowSales of Eli Lilly and Co.’s drugs in China are increasing at an even faster clip than the fast-growing nation’s overall pharmaceutical market, Reuters reports.
Lilly’s sales are rising about 26 percent a year compared with 16 percent for the entire drug industry in China, the world’s most populous country.
Lilly introduced five drugs to China this year and expects to sell 15 more in the next five years, Lilly China President Jorg Ostertag said.
China is expected to become the world’s seventh-largest pharmaceutical market in 2012 and the second-largest by 2020, he said.
Two years ago, Lilly partnered with China’s Hisun Group on drug development, and it plans to start more partnerships with Chinese firms, Ostertag said.
Please enable JavaScript to view this content.